Kevin Lynch

VP Gm, Gmp Operations @TriLink BioTechnologies, part of Maravai LifeSciences

San Diego, CA, US
EMAILS
k••••••••@trilinkbiotech.com
MOBILE NUMBERS
+14•••••••02

Signup · Get unlimited contacts

WORK HISTORY

Jun 2023 — Present

VP Gm, Gmp Operations @TriLink BioTechnologies, part of Maravai LifeSciences

View department →

San Diego, CA, US

TriLink BioTechnologies is a global leader in RNA synthesis and scale up, including mRNA production, yield-enhancing proprietary CleanCap® mRNA capping technology, and CDMO services ranging from research to GMP grades.

EDUCATION

1988 — 1992

University of Vermont

BS, Biology

1984 — 1988

Saint John's High School

Diploma, Biology, Chemistry

SKILLS

U.s. Title 21 Cfr Part 11 RegulationBiotechnologyProtein PurificationChange ControlCellGmpTechnology TransferCapaCell CultureQuality AssuranceVPharmaceutical IndustrySopFdaChromatography21 Cfr Part 11BiopharmaceuticalsLife SciencesLifesciencesPurificationU.s. Food and Drug Administration (Fda)VaccinesCommercializationQuality SystemAseptic ProcessingManufacturingStart-UpsStrategyProgram ManagementSupply Chain ManagementValidation

ABOUT KEVIN LYNCH

Kevin is an experienced life science executive with a proven track record of building high performance teams and ensuring successful transfer, scale, license approval and sustainability of various complex biopharmaceutical processes. He has worked for top-tier US and European organizations including Shire, Genzyme, and Sartorius Stedim and has extensive experience in specialty biopharmaceuticals including general management, sales, marketing, technical operations, strategic planning and compliance.Specialties: regenerative medicine, enzyme replacement therapies, diagnostics, vaccines, technical transfer, safety & compliance, regulations, growth and P&L Management, talent identification.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.